Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

New Hot Paper Comments

By H. Erich Wichmann

ESI Special Topics, March 2006
Citing URL - http://www.esi-topics.com/nhp/2006/march-06-HErichWichmann.html

H. Erich Wichmann answers a few questions about this month's new hot paper in the field of Social Sciences, general.


From •>>March 2006

Field: Social Sciences, general
Article Title: KORA - A research platform for population based health research
Authors: Holle, R;Happich, M;Lowel, H;Wichmann, HE;MONICA KORA Study Grp
Journal: GESUNDHEITSWESEN
Volume: 67
Issue: 
Page: :S19-S25
Year: Suppl. 1 AUG 2005
* GSF, Forschungszentrum Umwelt & Gesundheit, Inst Gesundheitsokon & Management Gesundheitswese, IGM, Ingolstadter Landstr 1, D-85758 Neuherberg, Germany.
* GSF, Forschungszentrum Umwelt & Gesundheit, Inst Gesundheitsokon & Management Gesundheitswese, IGM, D-85758 Neuherberg, Germany.
* GSF, Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, D-85758 Neuherberg, Germany.

ST:  Why do you think your paper is highly cited?


“...KORA-gen provides a proof of principle that existing population-based studies can successfully be used for genetic research.”

The paper describes the biobank KORA-gen which is based on an epidemiological cohort. This cohort has recently also been made available for genetic research by external partners. Meanwhile, KORA-gen is frequently used and has contributed to more than 70 genetic-epidemiological studies during the last three years. These are case-control studies, studies with quantitative traits, several meta-analyses, and comparisons with other populations.

To me, the paper has primarily been frequently cited for two main reasons: (i) because researchers are interested in the concept of opening local resources for the scientific community, and (ii) as a reference in publications where data from KORA-gen has been used.

ST:  Does it describe a new discovery or a new methodology that's useful to others?

KORA-gen is a new resource for genetic epidemiological studies. The objective is to provide access to DNA samples and phenotypic data from about 18,000 participants with mortality and morbidity follow-up for up to 20 years. These are adults from the general population who participated in four surveys of 4,000-5,000 subjects each. The individuals were from 25 to 74 years of age and randomly selected from a population of 600,000 citizens. Furthermore, data from two follow-up investigations will be available shortly, covering about 6,000 participants re-investigated after 7-10 years. Meanwhile, the oldest age group is now above 90 years old. In the underlying studies a wealth of information on sociodemography, environmental factors, smoking, nutrition, alcohol consumption, general medical history, and various laboratory parameters has been collected. Genomic DNA, serum plasma, and urine are available from most of the participants and also available are the immortalized cell lines from 1,500 persons.

The KORA-gen infrastructure covers aspects of study design, sampling, and matching, of DNA-handling and the determination of genetic markers, and also of data structures and formats. This is supported by Internet-based information and by providing competent individual counseling and assistance. A Web portal has been implemented to deliver information about available data and biosamples, rules about data ownership and data access, and the process of applying for a collaborative project. All genotypes are fed back into the common database for permanent storage.

The gradual accumulation of this genotypic information will add significant value to the overall dataset. In maintaining and administrating the central KORA-gen data base, the GSF National Research Center for Environment and Health acts as trustee. For all genetic and phenotype data items, ownership is given to those scientists who provided the data. Access to these data sets for scientific analyses is only granted with the permission of the data owners—based on the given rules of ethics and confidentiality, as well as the quality criteria.

ST:  Could you summarize the significance of your paper in layman's terms?

In KORA-gen important prerequisites for successful genetic-epidemiological research are fulfilled: (i) sufficiently large number of participants, (ii) well-characterized disease and intermediate phenotypes, (iii) well-recorded information about environmental factors and exposures, and (iv) the availability of biosamples.

Due to a broad, standardized phenotyping, it was possible to find or replicate genetic associations with several complex diseases and quantitative traits within KORA-gen. Examples were found of allergic diseases, cardiovascular diseases, diabetes, body-mass index (BMI), ECG parameters. One study on BMI has just been accepted for publication by Science.

We have started a KORA 500K Chip Project with several partners. In this project, 1,500 subjects who have participated in the basic survey and the follow-up investigation after 10 years will be genotyped by 500K chips. In this genome-wide approach, we will analyze several endpoints, such as type-2 diabetes, metabolic syndrome, hypertension, BMI, QT interval—the period that extends from the beginning of ventricular depolarization until the end of ventricular repolarization—left ventricular hypertrophy (LVH), inflammatory and lipid parameters, as well as the addiction to nicotine.

Since this sample of 1,500 persons is also representative for the general population, it can be used as a control group for case-control studies. This will drastically reduce the costs for genotyping, since the genotypes of the controls are already in place.

ST:  How did you become involved in this research, and were any problems encountered along the way?

We have performed classical epidemiological research since 1984/85, first within the WHO MONICA project (Monitoring of trends and determinants in cardiovascular disease) and then in the KORA project (Cooperative health research in the region of Augsburg). We started with cardiovascular questions and then expanded these activities to focus on other diseases. We established a common database and a trustee system for the mutual use of the data, co-financed by several partners. Since this system worked so efficiently and generated a large number and variety of publications—in total about 400 papers through the end of 2005—we thought of offering it to a broad spectrum of users who are interested in genetic research.

However, before this could be realized, questions of how to deal with data ownership, ethical issues, and questions of confidentiality needed to be resolved. In 2005, a Web site was established to facilitate the use of this valuable resource. Meanwhile KORA-gen is well accepted and frequently used by German researchers as well as by international scientists.

ST:  What are the social or political implications of your research?

KORA-gen demonstrates that existing population-based studies can successfully be used for genetic research. KORA-gen is based on the Cooperative Health Research Initiative in the region of Augsburg near Munich in Southern Germany. It is hosted and funded by the GSF-National Research Center for Environment and Health, as part of the Helmholtz Association. There is co-financing from the German National Genome Research Network (NGFN) and from several collaborators from among universities and research centers. KORA-gen is member of the Public Population Project in Genomics (P³G).End

Prof. dr. Dr. H. Erich Wichmann
Institut für Epidemiologie am GSF-Forschungszentrum für Umwelt und Gesundheit
Neuherberg, München, Germany


Related Links:

All external sites will open in a new browser. The Thomson Corporation and esi-topics.com does not endorse external sites.

ESI Special Topics, March 2006
Citing URL - http://www.esi-topics.com/nhp/2006/march-06-HErichWichmann.html

•> Search Special Topics
New Hot Papers Menu || All Topics Menu
New Hot Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.